GMED Globus Medical Inc Class A

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 4:30 pm Pacific Time

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.

Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of the Globus Medical investor relations website at .  

About Globus Medical, Inc. 

Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at .  

Investor contact: 

Brian Kearns 

610-930-1800 

 

Media contact: 

Moran Chavez 

 



EN
06/03/2025

Underlying

GMEDGlobus Medical Inc Class A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Globus Medical Inc Class A

 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical completes acquisition of Nevro Corp.

Globus Medical completes acquisition of Nevro Corp. AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chron...

April 3, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical extends versatility of Advanced Materials Science™ ante...

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion (ALIF) surgery, andModulus™ ALIF Blades: An extension of the market-leading Modulus™ ALIF interbody spacer system. The COHERE ™ ALIF Spacer is the latest addition to...

March 11, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty a...

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in San Diego, Calif., from March 10-14, 2025. Join Globus at booth #2517 to learn about the comprehensive Globus Medical product portfolio across Spine, Trauma, and Joint Reconstruction procedures; Enabling Technolog...

March 6, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical to participate in the Canaccord Genuity 2025 Musculoske...

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference Monday, March 10, 2025 at 4:30 pm Pacific Time AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT. Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of...

March 6, 2025 1 EN
Free Trial
GMED Globus Medical ...

Globus Medical Inc: 1 director

A director at Globus Medical Inc sold 7,500 shares at 78.680USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

GMED GLOBUS MEDICAL INC CLASS A
03/05/25 March 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch